Abstract
High-dose ultraviolet (UV) A1 therapy (doses in the order of 130 J cm(-2)) is effective for atopic dermatitis and scleroderma. UVA1 has been shown to induce a dose-dependent increase in p53 expression in keratinocytes.
Original language | English |
---|---|
Pages (from-to) | 1001-8 |
Number of pages | 8 |
Journal | British journal of dermatology |
Volume | 152 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2005 |
Keywords / Materials (for Non-textual outputs)
- Adult
- Apoptosis
- Cell Cycle Proteins
- Cyclin-Dependent Kinase Inhibitor p21
- Erythema
- Humans
- Middle Aged
- Phosphorylation
- Radiation Dosage
- Radiation Injuries
- Skin
- Sunlight
- Tumor Suppressor Protein p53
- Ultraviolet Rays